RAC - Charts & Price Action, page-15814

I don’t think people are ‘happy’ it’s falling, some are just taking the opportunity to buy more. I reckon most would prefer this to still be at $1.80 as you mentioned. This stock is cooked atm but positive clinical data will change that whenever it comes.. I’d be concerned if we had to raise money but we don’t unlike another bio stock I’m in that looks to have quite a bright outlook but needs cash soon and we are praying for a partnership or deal. You would be hard pressed to find too many stocks/bio stocks that are doing any good so I’m not sure there is much of an opportunity cost that’s hurting investors in this. This will turn and I hope you still have your shares when it does